How AI Is Reducing Drug Development Timelines From Years to Months
Today, artificial intelligence (AI) is changing this story. With the help of AI, scientists and companies are finding ways to shrink drug development timelines from years to months. Reshaping the pharmaceutical industry can accelerate drug development, improve efficiency, and potentially increase the success of projects.
Transgender Representation in Biotech: Why It Matters for Science and Patients
Transgender people are part of every community, including biotech. Representation means that transgender scientists, clinicians, engineers, and staff are visible, heard, and included. When biotech companies and research teams include transgender people, scientific outcomes improve.
Innovation in Biotech Requires a First Leap
Real innovation requires a first leap. It requires someone to move beyond accepted limits and step into unexplored territory. If no person takes that first leap, then the field does not truly move forward.
Pharma's Future: Addressing Political Challenges to DEI
As national debates over diversity, equity, and inclusion (DEI) continue to intensify, these conflicts are beginning to shape biomedical policy, clinical research, workforce development, and the long-term direction of American innovation.
Is Coffee Bad for the Heart? What a New Trial Says About Coffee and Atrial Fibrillation
For many years, people have heard that coffee is bad for the heart. Doctors often warn patients with heart rhythm problems to stay away from caffeine because it might trigger an irregular heartbeat. This belief has been part of common medical advice for decades. Coffee is one of the most popular drinks in the world, and many people depend on it to start their day. As a result, the question of whether coffee harms or benefits the heart has become very important for both patients and clinicians.